Results 321 to 330 of about 9,559,132 (390)
The prototype carbon Fund, a public/ private collaboration in the emerging environmental market
Solen Maheo
openalex +1 more source
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
The European Nucleotide Archive in 2025. [PDF]
David Y +27 more
europepmc +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Article processing charges and health research output in low-income countries: funding cuts, implications for health policy and system management. [PDF]
Eneh SC +11 more
europepmc +1 more source
Formation of the fund of foreign literature in Kuibyshev (1944–1946)
S. D. Chebotarev
openalex +2 more sources

